CD274 and neoplasm: Previous studies have also shown that tumor cells and the tumor microenvironment could up-regulate PD-L1, activate PD-1/PD-L1 signaling pathways, inhibit T cell activation and proliferation, and induce T cell apoptosis (10, 11).